BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang D, Jiao Y. Pancreatogenic diabetes: Pathophysiology, diagnosis, and management challenges. World J Gastrointest Surg 2025; 17(11): 112204 [PMID: 41357647 DOI: 10.4240/wjgs.v17.i11.112204]
URL: https://www.wjgnet.com/1948-9366/full/v17/i11/112204.htm
Number Citing Articles
1
Ana Meden, Dušanka Mičetić-Turk. Resveratrol in diabetes and pancreatic function: implications for the exocrine–endocrine pancreatic axis–a systematic reviewFrontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1806881
2
Mathew Vadukoot Lazar, Arun C.S. Menon, Jibu Thomas. Type 3c Diabetes Mellitus: Epidemiology, Diagnosis, Management, and Research Imperatives With Insights From the United Arab Emirates and Global ContextsCureus 2026;  doi: 10.7759/cureus.105089
3
Juliana Moreira Batista, Camily do Socorro Pinheiro Cardoso, Diego Barata Bandeira. DESAFIO DIAGNÓSTICO EM DISTÚRBIOS HIPERGLICÊMICOS APÓS CIRURGIA DE WHIPPLE: RELATO DE CASO E REVISÃO DE LITERATURARevista Contemporânea 2026; 6(2): e10288 doi: 10.56083/RCV6N2-033
4
Xiaoping Han, Ying Geng, Yifang Li, Xianglong Meng, Jian Jiao. Roles of peroxisome proliferator-activated receptors (PPARs) in pancreatic metabolic diseasesPharmacological Research 2026; 227: 108192 doi: 10.1016/j.phrs.2026.108192
5
Erika Kvalem Soto, Valeria Wagner, Julia Engl, Michael Mederer, Veronika Cibulkova, Johanna Piater, Benedikt Schäfer, Elena Dunzendorfer, Silvio Waschina, Susanne Kaser, Konrad Aden, Zlatko Trajanoski, Herbert Tilg, Maria Effenberger. Escherichia-Shigella expansion and metabolite dysregulation in type 3c diabetes: linking microbiome alterations to exocrine pancreatic insufficiencyFrontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1786756